Showing results (101-110 of 140) with videos related to
Sort By:
Pageof 14
Frontiers in Immunology|February 16, 2026
Tumor-reactive TCRs within exhausted TILs reveal cancer type-specific immune landscapes in renal cell carcinomaMitsuru Komahashi, Shun Horaguchi, Kayoko Tsuji, et al.Breast Cancer Research : BCR|July 5, 2014
Feasibility study of personalized peptide vaccination for metastatic recurrent triple-negative breast cancer patientsRyuji Takahashi, Uhi Toh, Nobutaka Iwakuma, et al.International Journal of Oncology|October 14, 2014
Feasibility study of personalized peptide vaccination for advanced non-small cell lung cancer patients who failed two or more treatment regimensTeppei Yamada, Yasuhiro Terazaki, Shinjiro Sakamoto, et al.Frontiers in Immunology|October 20, 2025
Machine learning-based insights into circulating autoantibody dynamics and treatment outcomes in patients with NSCLC receiving immune checkpoint inhibitorsFeifei Wei, Hiroyuki Takeda, Koichi Azuma, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 14, 2016
Vaccination with Irradiated Autologous Tumor Cells Mixed with Irradiated GM-K562 Cells Stimulates Antitumor Immunity and T Lymphocyte Activation in Patients with Recurrent Malignant GliomaWilliam T Curry, Ramana Gorrepati, Matthias Piesche, et al.British Journal of Haematology|September 17, 2013
Identification of human leucocyte antigen (HLA)-A*0201-restricted cytotoxic T lymphocyte epitopes derived from HLA-DOβ as a novel target for multiple myelomaYoon Joong Kang, Wanyong Zeng, Weihua Song, et al.Cancer Immunology, Immunotherapy : CII|February 7, 2020
Mixed 20-peptide cancer vaccine in combination with docetaxel and dexamethasone for castration-resistant prostate cancer: a randomized phase II trialMasanori Noguchi, Gaku Arai, Shin Egawa, et al.Cancer Science|February 28, 2016
Phase I study of a new cancer vaccine of ten mixed peptides for advanced cancer patientsSatoru Iwasa, Yasuhide Yamada, Yuji Heike, et al.Journal for Immunotherapy of Cancer|May 15, 2022
Clinical significance of plasma-free amino acids and tryptophan metabolites in patients with non-small cell lung cancer receiving PD-1 inhibitor: a pilot cohort study for developing a prognostic multivariate modelKoichi Azuma, Huihui Xiang, Tomoyuki Tagami, et al.Molecular Cell|April 5, 2002
Peptide-induced negative selection of thymocytes activates transcription of an NF-kappa B inhibitorEmma Fiorini, Ingo Schmitz, Wilfred E Marissen, et al.Pageof 14